November 19, 2019 – On November 19, 2019, a North Carolina woman filed a Zantac lawsuit in the U.S. District Court for the Western District of North Carolina. She claimed that after taking Zantac for years, she was diagnosed with stomach cancer, which she blamed on the drug. She had started taking Zantac regularly in 1992 and continued to...
Continue ReadingNovember 15, 2019 – In the past week, three generic Zantac drugs have been recalled from pharmacy shelves across the U.S as concern grows that the drugs are linked to an increased risk of cancer. Amneal Pharmaceuticals recalled dozens of lots of Ranitidine Tablets and Ranitidine Syrup.The decision was made amid concerns that the Ranitidine Tablets and Ranitidine Syrup contain...
Continue ReadingNovember 10, 2019 – The FDA issued warnings about cancer risks associated with Zantac after finding unacceptable levels of the probable carcinogen NDMA while testing it and its generic, ranitidine, earlier in September. Zantac had been prescribed more than 15 million times a year without safety concerns prior to the FDA’s announcement. The agency wanted manufacturers to test and recall...
Continue ReadingOctober 18, 2019 — On October 18, 2019, Sanofi recalled over-the-counter Zantac in the United States and Canada. Reference: “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.
Continue ReadingOctober 8, 2019 — On October 8, 2019, GlaxoSmithKline recalled prescription-only Zantac medicines in all its markets. GlaxoSmithKline was the original maker of Zantac. Reference: “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.
Continue ReadingOctober 2, 2019 — On October 2, 2019, the FDA said it found “unacceptable levels” of NDMA in samples of ranitidine in its testing. Reference: “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21 Oct. 2019, www.reuters.com/article/us-health-fda-heartburn-timeline/timeline-popular-heartburn-medicine-zantac-pulled-off-store-shelves-idUSKBN1X014E.
Continue ReadingSeptember 28, 2019 — On September, 28, 2019, the drugstore chain CVS Health Corp said it would stop selling Zantac and its own generic ranitidine products. Walmart Inc, Walgreens Boots Alliance Inc and Rite Aid Corp also started removing the drugs off of their shelves. Reference: “Timeline: Popular Heartburn Medicine Zantac Pulled off Store Shelves.” Reuters, Thomson Reuters, 21...
Continue ReadingSeptember 13, 2019 — On September 13, 2019, the FDA issued a public safety warning about the NDMA found in samples of ranitidine. Reference: “NDMA in Zantac (Ranitidine).” U.S. Food and Drug Administration, FDA, www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine.
Continue ReadingSeptember 2019 — A federal jury ruled in Sanofi’s favor in the first bellwether trial to allow the parties to gauge the value of the remaining claims and inform potential settlement talks. Reference: Raymond, Nate. “Warning Label Change for Sanofi’s Taxotere Dooms 200 Hair Loss Cases – Judge.” Reuters, Thomson Reuters, 28 May 2020, www.reuters.com/article/products-taxotere/warning-label-change-for-sanofis-taxotere-dooms-200-hair-loss-cases-judge-idUSL1N2DA1ZO
Continue ReadingApril 2019 — There were 11,430 Taxotere lawsuits pending as of April 2019. Reference: “Taxotere Lawsuit – Permanent Hair Loss and Illegal Marketing.” Drugwatch.com, 20 Apr. 2020, www.drugwatch.com/taxotere/lawsuits/
Continue Reading